BUY Glenmark Pharmaceuticals — Prashant P. Sawant, 13 Aug 2026

byPrashant P. SawantHorizon: NA (inferred Intraday)13 Aug 2026, 1:05 pm ISTvia CNBC Awaaz.

Entry₹2,302.7Inferred

Target₹2,350

Stop loss₹2,275-1.20% risk

At expiry₹2,318.513 Aug 2026, 3:05 pm

Expired+0.69%

Follow Prashant P. Sawant for new calls(5% target hit, 21 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Aug 2026

1 supporting1 neutral2 opposing

Supports the BUY call (1)

3 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·12 Aug · yesterday

Neutral / worth noting (1)

Glenmark USA has agreed to a settlement of $15.28 million to resolve antitrust and consumer protection lawsuits related to price-fixing allegations. The company denies all allegations and states the s

BSE · Company Update·11 Aug · yesterday

Weighs against the BUY call (2)

Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

NewsCnbc-Tv18·12 Aug · yesterday

1 advisor has an active swing SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·7 Aug · 6d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.